Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Accounts Payables: 2013-2019

Historic Accounts Payables for Soleno Therapeutics (SLNO) over the last 5 years, with Sep 2019 value amounting to $1.7 million.

  • Soleno Therapeutics' Accounts Payables rose 39.36% to $1.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $1.7 million, marking a year-over-year increase of 39.36%. This contributed to the annual value of $934,000 for FY2018, which is 47.55% up from last year.
  • As of Q3 2019, Soleno Therapeutics' Accounts Payables stood at $1.7 million, which was down 0.29% from $1.7 million recorded in Q2 2019.
  • In the past 5 years, Soleno Therapeutics' Accounts Payables ranged from a high of $1.7 million in Q2 2019 and a low of $410,512 during Q4 2016.
  • For the 3-year period, Soleno Therapeutics' Accounts Payables averaged around $1.1 million, with its median value being $1.0 million (2017).
  • Data for Soleno Therapeutics' Accounts Payables shows a peak YoY increase of 103.22% (in 2016) and a maximum YoY decrease of 40.94% (in 2016) over the last 5 years.
  • Soleno Therapeutics' Accounts Payables (Quarterly) stood at $695,056 in 2015, then tumbled by 40.94% to $410,512 in 2016, then spiked by 54.20% to $633,000 in 2017, then spiked by 47.55% to $934,000 in 2018, then spiked by 39.36% to $1.7 million in 2019.
  • Its Accounts Payables was $1.7 million in Q3 2019, compared to $1.7 million in Q2 2019 and $1.3 million in Q1 2019.